Posts

Innate Immune Training: A Catalyst for Increased Inflam...

Recent studies have revealed profound insights into the innate immune system, ch...

Mayo Clinic Honored as ‘World’s Best Hospital’ by Newsw...

ROCHESTER, Minn. — Once again, Mayo Clinic has earned the prestigious position o...

Rare Childhood Metabolic Crises Explained by Fat Transp...

Researchers at the Centre for Genomic Regulation (CRG) in Barcelona have made a ...

Collaboration Between Roadway Safety Research and Autom...

The University of Michigan (U-M), renowned for its rich legacy in transportation...

Revolutionary Ancient RNA-Guided Mechanism May Streamli...

image:  The Tas protein uses an RNA guide to recognize a specific target DNA seq...

Unexpectedly High Rates of Critical Illness in African ...

In a groundbreaking study published in The Lancet, the alarming realities of cri...

How Our Lungs Support Bone Marrow in Blood Production

Recent discoveries in hematology have sparked a new conversation about the biolo...

Employee Burnout: A Multimillion-Dollar Burden for Empl...

The Financial Fallout of Employee Burnout: A Wake-Up Call for Corporations In re...

Breakthrough in Transparent, Stretchable Substrates Pro...

In a groundbreaking development that holds immense promise for future technologi...

Extensive Population Research Reveals Chronic Health Ri...

A large-scale study conducted in France has elucidated the enduring health chall...

Enhancing Document-Level Event Role Filler Extraction w...

Groundbreaking Advances in Document-Level Role Filler Extraction Through Innovat...

Why Are Pandas Primarily Herbivorous? Research Links Ba...

In a remarkable intersection of two seemingly distant realms of biology, researc...

RedHill and Hyloris sign agreement for Bekinda’s develo...

RedHill has signed an exclusive licensing agreement with Hyloris for the global ...

Eli Lilly pays $10m upfront for Organovo’s FXR agonist

Organovo’s lead asset FXR314 will be investigated in a Phase II trial for inflam...

FDA grants breakthrough status to Grin Therapeutics’ ra...

The US Food and Drug Administration (FDA) has granted breakthrough therapy desig...

FDA grants fast track status to Pyxis’ PYX-201

The FDA has granted fast track designation to Pyxis oncology’s PYX-201 for the t...